IGF-1 DES 10 mg

About IGF-1 DES

IGF-1 DES (Des(1-3) IGF-1) is a truncated variant of native IGF-1. By omitting the first three N-terminal amino acids, binding affinity to circulating inhibitory IGFBPs is attenuated by up to 90%, leaving the peptide free to bind the IGF-1 receptor with up to 10-fold higher potency. Its short half-life makes it the gold standard for site-specific localized tissue regeneration experiments.

Pen technology & delivery format

IGF-1 DES is supplied in the NADOVA LABS GoQuick pre-filled pen — a graduated, 3 mL dial-calibrated laboratory dispensing system engineered to eliminate reconstitution variability, aerosolization, and volumetric measurement errors in repeat-dose research designs. Each pen is pre-filled with ≥99% HPLC-authenticated research peptide solution, features a tactile dial-a-dose click mechanism, and is preserved under 2–8 °C cold-chain storage with a verifiable batch Certificate of Analysis.

Handling & research compliance

This pre-filled pen is intended strictly for in-vitro and laboratory research use by qualified scientific investigators. It is not an approved medicine, medical device, food, or supplement, and is not for human or veterinary use, ingestion, or injection. Store refrigerated at 2–8 °C, protect from direct light, and follow accepted laboratory safety procedures. Statements have not been evaluated by any regulatory authority (FDA, EMA).